CAS: 1929519-13-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TAK-041 REF: IN-DA0200XHCAS: 1929519-13-0 | 98% | 124.00 €~758.00 € | Fri 15 Nov 24 |
 | TAK-041 REF: TM-T9317CAS: 1929519-13-0 | 99.95% | 66.00 €~1,104.00 € | Fri 22 Nov 24 |
 | TAK-041 REF: 3D-ECD51913CAS: 1929519-13-0 | Min. 95% | To inquire | Fri 27 Dec 24 |
Ref: IN-DA0200XH
| 25mg | 124.00 € | ||
| 50mg | 195.00 € | ||
| 100mg | 223.00 € |
Estimated delivery in United States, on Friday 15 Nov 2024
TAK-041
CAS:1929519-13-0
TAK-041 (NBI-1065846) is a potent and selective GPR139 agonist.
Formula:
C18H15F3N4O3
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
392.33
Ref: TM-T9317
| 1mg | 66.00 € | ||
| 5mg | 142.00 € | ||
| 10mg | 220.00 € | ||
| 25mg | 442.00 € | ||
| 50mg | 707.00 € | ||
| 100mg | 1,104.00 € | ||
| 1mL*10mM (DMSO) | 156.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
TAK-041
CAS:1929519-13-0
TAK-041 is an analog of a protein that acts as an anticancer agent by inhibiting …
Formula:
C18H15F3N4O3
Purity:
Min. 95%
Molecular weight:
392.3 g/mol
Ref: 3D-ECD51913
| 50mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
